Home/Filings/4/0001415889-25-002292
4//SEC Filing

Szela Mary T 4

Accession 0001415889-25-002292

CIK 0001826667other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 6:15 PM ET

Size

11.6 KB

Accession

0001415889-25-002292

Insider Transaction Report

Form 4
Period: 2025-01-27
Szela Mary T
DirectorCEO AND PRESIDENT
Transactions
  • Award

    Common Stock

    2025-01-27+40,000424,677 total
  • Purchase

    Common Stock

    2025-01-27$5.42/sh+4,826$26,157429,503 total
  • Award

    Employee Stock Option (right to buy)

    2025-01-27+240,000240,000 total
    Exercise: $5.30Exp: 2035-01-26Common Stock (240,000 underlying)
  • Purchase

    Common Stock

    2025-01-28$5.12/sh+4,716$24,146434,219 total
Footnotes (4)
  • [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.25 to $5.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Issuer

TriSalus Life Sciences, Inc.

CIK 0001826667

Entity typeother

Related Parties

1
  • filerCIK 0001410289

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:15 PM ET
Size
11.6 KB